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Regulation of exocytosis by the exocyst subunit 
Sec6 and the SM protein Sec1
Francesca Morgeraa, Margaret R. Sallaha, Michelle L. Dubukea, Pallavi Gandhia, Daniel N. Brewera, 
Chavela M. Carrb, and Mary Munsona
aDepartment of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, 
MA 01605; bDepartment of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77840
ABSTRACT Trafficking of protein and lipid cargo through the secretory pathway in eukary-
otic cells is mediated by membrane-bound vesicles. Secretory vesicle targeting and fusion 
require a conserved multisubunit protein complex termed the exocyst, which has been impli-
cated in specific tethering of vesicles to sites of polarized exocytosis. The exocyst is directly 
involved in regulating soluble N-ethylmaleimide–sensitive factor (NSF) attachment protein 
receptor (SNARE) complexes and membrane fusion through interactions between the Sec6 
subunit and the plasma membrane SNARE protein Sec9. Here we show another facet of Sec6 
function—it directly binds Sec1, another SNARE regulator, but of the Sec1/Munc18 family. 
The Sec6–Sec1 interaction is exclusive of Sec6–Sec9 but compatible with Sec6–exocyst as-
sembly. In contrast, the Sec6–exocyst interaction is incompatible with Sec6–Sec9. Therefore, 
upon vesicle arrival, Sec6 is proposed to release Sec9 in favor of Sec6–exocyst assembly and 
to simultaneously recruit Sec1 to sites of secretion for coordinated SNARE complex forma-
tion and membrane fusion.
INTRODUCTION
Exocytosis in eukaryotes requires the accurate trafficking of mem-
brane-bound vesicles between functionally and chemically distinct 
organelles and to the plasma membrane for growth, secretion, and 
cell–cell communication. Trafficking is a conserved and highly regu-
lated process, employing multiple classes of essential proteins to 
ensure proper spatial and temporal cargo delivery (Wickner and 
Schekman, 2008, and references therein). Soluble N-ethylmaleim-
ide–sensitive factor (NSF) attachment protein receptor (SNARE) 
proteins on the target membrane (t-SNAREs) and vesicle (v-SNAREs) 
form a four-helix bundle called the SNARE complex, which bridges 
the membranes for fusion. The formation of specific, fusion-com-
petent SNARE complexes is regulated by multiple protein families, 
including tethering factors such as the exocyst (Munson and Novick, 
2006; He and Guo, 2009) and the Sec1/Munc18 (SM) proteins 
(Sudhof and Rothman, 2009). The actions of tethers and SM pro-
teins are likely to be coordinated at vesicle docking sites, but in 
many cases, direct evidence connecting them is lacking (Toonen 
and Verhage, 2003; Carr and Rizo, 2010).
The exocyst is a large conserved heterooligomeric complex that 
is essential for growth and secretion; it functions in exocytosis, endo-
cytosis, cytokinesis, and autophagy, and has been implicated in cil-
iogenesis, cancer, and bacterial pathogenesis (TerBush et al., 1996; 
Guo et al., 1999; He and Guo, 2009; Munson and Novick, 2006; Wu 
et al., 2008; Nichols and Casanova, 2010). It is composed of eight 
subunits—Sec3, Sec5, Sec6, Sec8, Sec10, Sec15, Exo70, and 
Exo84—which localize to sites of polarized growth and secretion 
through binding phosphoinositides (He et al., 2007; Baek et al., 
2010; Yamashita et al., 2010) and small GTPases of the Ras super-
family (Wu et al., 2008; He and Guo, 2009). The exocyst, a member 
of the CATCHR family of tethering complexes (including COG, Dsl1, 
and GARP; Whyte and Munro, 2002; Koumandou et al., 2007; 
Munson, 2009; Yu and Hughson, 2010), has been proposed to tether 
secretory vesicles to the plasma membrane; however, there is little 
direct evidence for tethering activity by any of these complexes.
The exocyst subunit Sec6 plays critical roles in several aspects of 
exocyst function. As with many of the exocyst subunits, Sec6 was 
originally discovered as a temperature-sensitive sec mutant of the 
secretory pathway (Novick et al., 1980). At the restrictive tempera-
ture, the sec6-4 mutant strain shows a loss of exocyst stability, with 
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stand the functional interplay among these proteins, we examined 
their relationships with one another both in vitro and in vivo.
RESULTS
Sec1 interacts with the exocyst subunit Sec6
For direct examination of the interactions between the exocyst sub-
units and Sec1, we purified Sec1-V5-His6 (hereafter called Sec1) 
from yeast and immobilized it using an α-V5 antibody on Protein G 
resin (as in Togneri et al., 2006). Purified recombinant exocyst sub-
units were individually tested for their ability to bind Sec1. Of the 
eight exocyst subunits, Sec6 (Sivaram et al., 2005), Sec8 (Sivaram 
et al., 2006), Sec10 (amino acids 145–827; Croteau et al., 2009), 
Exo70 (63–623; Dong et al., 2005), and the C-terminal region of 
Exo84 (523–753; Dong et al., 2005) were soluble; the other sub-
units were not tested. Purified Sec6 was the only subunit to robustly 
and specifically interact with Sec1 (Figure 1, A–C). The apparent 
dissociation constant (Kd) between Sec1 and Sec6, based on the 
pull-down assay, was ∼1.7 ± 0.4 μM (Figure 1D). This affinity is 
slightly weaker than the apparent Kd for the Sec6–Sec9 interaction, 
∼0.5 μM (Sivaram et al., 2005), and for the Sec1–SNARE complex 
interaction, ∼0.3 μM (Togneri et al., 2006). The Sec6–Sec1 binding 
interaction was reciprocal; Sec6 immobilized using a C-terminal 
Strep affinity tag bound to purified Sec1 (Figure 1E). Previous map-
ping indicated that the N-terminal domain of Sec6 is required for 
dimerization and for binding to both Sec9 and the exocyst subunit 
Sec8 (Sivaram et al., 2005, 2006). Conversely, the Sec6 C-terminal 
domain (411–805) is sufficient for binding the exocyst subunits 
Sec10 and Exo70 (Sivaram et al., 2006). Here we demonstrate that 
the Sec6 C-terminal domain is not sufficient for Sec1 binding 
(Figure 1B), indicating that the N-terminal domain of Sec6 is also 
necessary for the Sec6–Sec1 complex. The insolubility of the Sec6 
N-terminal domain in isolation has thus far precluded direct testing 
of this region.
As a positive control, purified Sec1 was analyzed to ensure spe-
cific binding of Sec1 to ternary SNARE complexes containing Sec9, 
its partner t-SNARE Sso1 (the yeast exocytic syntaxin), and the v-
SNARE Snc2 (Togneri et al., 2006; Figure 2A). We also found that 
both Sec9 and Sso1 can weakly bind to Sec1 at high concentrations 
(≥10 and ≥20 μM, respectively; Figure 2, B and C). These interactions 
had not been previously observed, likely due to the lower protein 
concentrations used in those experiments (≤10 μM; Scott et al., 
2004; Togneri et al., 2006). However, these interactions are not com-
pletely unexpected, because binding of nonsyntaxin SNAREs has 
been observed for other SM proteins (Peng and Gallwitz, 2004; 
Carpp et al., 2006; Xu et al., 2010).
Analytical gel filtration analyses confirmed the Sec6–Sec1 in-
teraction in solution (Figure 3). Sec1 migrates as a monomer, 
whereas Sec6 runs predominantly as a dimer, with a shoulder in 
the gel filtration peak that is compatible with a small amount of 
monomeric Sec6 (including the affinity tags, Sec1 is 89 kDa and 
Sec6 is 95 kDa). Dimerization of Sec6 was previously reported 
(Sivaram et al., 2005); however, the presence of the Sec6 mono-
mer was not demonstrated because the method of detection 
used for the analyses was less sensitive (Coomassie-stained gels 
vs. Western blots analyzed with a specific α-Sec6 antibody). The 
Sec6–Sec1 complex, as inferred from the increased apparent mo-
lecular weight of Sec1, migrates with an apparent molecular 
weight comparable to that of the Sec6 dimer (apparent molecular 
weight ∼180 kDa), suggesting that the Sec6–Sec1 complex has a 
1:1 stoichiometry, with Sec1 binding to the monomeric form of 
Sec6. This is in contrast to the previously characterized 2:2 stoichi-
ometry for the Sec6–Sec9 complex (Figure 3; Sivaram et al., 2005) 
defects in polarized growth and secretion (TerBush and Novick, 
1995). Additional temperature-sensitive mutations in conserved 
residues on the surface of the Sec6 C-terminal domain (Sivaram 
et al., 2006) led to loss of localization of the exocyst without com-
plex disassembly (Songer and Munson, 2009). These residues are 
proposed to maintain exocyst localization through interactions with 
anchoring factor(s) at sites of secretion. Sec6 also binds the reticulon 
Rtn1, implicating Sec6 in the organization of cortical endoplasmic 
reticulum structure (De Craene et al., 2006). Moreover, we previ-
ously showed that the yeast exocyst subunit Sec6 interacts with the 
plasma membrane t-SNARE Sec9, inhibiting the formation of Sec9-
containing SNARE complexes in vitro (Sivaram et al., 2005). Because 
the loss of Sec6 function in sec6-4 results in a block in SNARE as-
sembly (Grote et al., 2000), the Sec6–Sec9 interaction we observe 
may be a critical intermediate in the assembly of SNARE 
complexes.
The SM protein family is essential for regulating SNARE proteins 
and SNARE-mediated membrane fusion. Although members of the 
SM family all bind individual SNARE proteins and/or SNARE com-
plexes, several distinct modes of interaction have been reported, 
raising the possibility that SM proteins have multiple functions via 
different mechanisms (Toonen and Verhage, 2003, 2007; Carr and 
Rizo, 2010). The best-characterized SM protein, Munc18-1 (neuronal 
Sec1), binds to 1) the “closed” inhibited conformation of the t-
SNARE syntaxin-1a (Misura et al., 2000); 2) the N-terminus of syn-
taxin-1a (Burkhardt et al., 2008); and 3) ternary SNARE complexes 
containing syntaxin-1a (Dulubova et al., 2007; Shen et al., 2007; 
Rodkey et al., 2008; Xu et al., 2010). A similar constellation of bind-
ing interactions has been reported for the endosomal SM protein 
Vps45 (Carpp et al., 2006; Furgason et al., 2009). Other SM proteins 
such as Sly1 appear to bind only the N-terminus of the partner syn-
taxin (Bracher and Weissenhorn, 2002; Yamaguchi et al., 2002; Peng 
and Gallwitz, 2004; Arac et al., 2005). In contrast, the yeast Sec1 
protein interacts predominantly with assembled ternary SNARE 
complexes and not with the syntaxin Sso1 (Carr et al., 1999; Togneri 
et al., 2006). Functionally, several SMs appear to have an inhibitory 
role in SNARE complex assembly, whereas other studies clearly 
identified a positive role for SM proteins in SNARE complex assem-
bly and membrane fusion (Gallwitz and Jahn, 2003; Scott et al., 
2004; Shen et al., 2007; Toonen and Verhage, 2007). Thus, the func-
tions of SM proteins, the mechanism(s) underlying these functions, 
and the extent to which these functions are conserved all remain 
important and incompletely resolved questions.
Although our Sec6–Sec9 binding studies indicated that the 
exocyst may play a direct role in controlling SNARE complex as-
sembly, the question remained: how is Sec6 inhibition of Sec9 re-
leased to promote SNARE complex assembly? Several studies 
suggested that the exocyst might function with or through the SM 
protein Sec1 to regulate SNARE complex assembly (Finger and 
Novick, 2000; Grote et al., 2000; Wiederkehr et al., 2004; 
Hashizume et al., 2009), and the exocyst and Sec1 are specifically 
localized to sites of secretion in yeast. Although evidence pointed 
to a function for Sec1 after SNARE complex assembly by binding 
assembled SNARE complexes (Carr et al., 1999; Scott et al., 2004; 
Togneri et al., 2006) and promoting liposome fusion in vitro (Scott 
et al., 2004), a recent analysis of a large panel of Sec1 mutants 
demonstrated an additional functional requirement for Sec1 prior 
to SNARE complex assembly (Hashizume et al., 2009). Further-
more, overexpression of Sec1 resulted in increased levels of 
SNARE complexes (Wiederkehr et al., 2004). We hypothesized, 
therefore, that the exocyst and Sec1 work together to directly 
regulate the SNAREs and SNARE complex assembly. To under-
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Interestingly, addition of equimolar 
amounts of Sec1, Sec6, and Sec9 together 
resulted in a Sec6–Sec9 complex (apparent 
molecular weight, ∼235 kDa) and mono-
meric Sec1 (apparent molecular weight, 
∼90 kDa). Ternary Sec6-Sec9-Sec1 com-
plexes were not observed. Thus, Sec9 ro-
bustly competes with Sec1 for Sec6 binding, 
suggesting that either the Sec1- and Sec9-
binding sites on Sec6 are similar or that Sec1 
binding induces an allosteric conformational 
change in Sec6 that is incompatible with 
Sec9 binding. Furthermore, Sec1 binding 
appears to compete with Sec6 dimerization, 
whereas two molecules of Sec9 bind per 
Sec6 dimer. These data are supported by 
our results showing that the N-terminal do-
main of Sec6 is required for binding both 
Sec1 and Sec9 and also for dimerization 
(Figure 1B; Sivaram et al., 2005). However, 
because Sec1 competes with Sec6 dimeriza-
tion while Sec9 does not, the binding sites 
for Sec1 and Sec9 on Sec6 are not identical 
but likely overlap.
Sec6–exocyst interacts with Sec1, 
whereas non-exocyst-bound Sec6 
binds to Sec9
To test Sec6 interactions in vivo, α-HA anti-
body was used to immunoprecipitate Sec6-
HA3 from yeast lysates. A small fraction of 
Sec9 coimmunoprecipitated with Sec6, un-
less Sec9 was overexpressed (Figure 4A). 
Nonspecific binding of Sec1 to the α-HA an-
tibody produced high background levels; 
therefore, we expressed Sec1-V5 in the 
Sec6-HA3 strain and immunoprecipitated 
Sec1 with the α-V5 antibody. Sec6 coimmu-
noprecipitated with Sec1-V5 (Figure 4B); the 
amount of Sec6 coimmunoprecipitated was 
consistently above background levels, al-
though the amount bound was only a frac-
tion (∼1%) of the total Sec6 in the cell. This 
low percentage was similar to the amount 
that we observed for the Sec6–Sec9 interac-
tion (Figure 4A). In contrast, the other exo-
cyst subunits readily coimmunoprecipitate 
with Sec6-HA3 (Songer and Munson, 2009). 
The Sec1–Sec6 data are consistent with pre-
vious results from the Novick lab, in which a 
comparable amount (∼0.2–0.4%) of Sec1 
bound to the exocyst complex, when coim-
munoprecipitated with either Sec8-Myc or 
Sec10-Myc (Wiederkehr et al., 2004). To-
gether, these results suggested that Sec1 
can interact with exocyst-bound Sec6.
We tested whether recombinant Sec6 
could interact with Sec1 while bound to 
other exocyst subunits in vitro. The pairwise 
affinities of the exocyst–exocyst interactions appear to be quite 
weak (estimated >10 μM; Dong et al., 2005; Sivaram et al., 2006). 
Therefore we analyzed the binding of Sec6–Sec1 to a combination 
but is consistent with the stoichiometry determined for the as-
sembled exocyst complex of one subunit each per complex 
(TerBush et al., 1996).
FIGURE 1: Sec1 interacts with the exocyst subunit Sec6. (A) Purified Sec1-V5-His6 was 
immobilized with α-V5 antibody and mixed with purified exocyst subunits: Sec6, Exo70 (63–623), 
and Sec10 (145–827). Input and bound samples were run on an 8% SDS–PAGE gel and stained 
with Coomassie blue dye. (B) Similar experiments were performed using the C-terminal domain 
(411–805) of Sec6 and Exo84 (523–753). Input and bound samples were run on a 12% 
SDS–PAGE gel and stained with Coomassie blue dye. Only full-length Sec6 bound to Sec1. 
(C) Sec1-V5-His6 was immobilized and incubated with Ni NTA–purified His6-Sec8. In this case, 
the input and bound proteins (which are all His6 tagged) were analyzed by Western blotting 
using α-His5 antibody. (D) Representative binding curve for Sec6–Sec1. Sec1 was immobilized 
on beads and incubated with increasing concentrations of Sec6. The apparent binding constant 
was 1.7 ± 0.4 μM (mean ± SEM) from fits to three different experiments. (E) The Sec6–Sec1 
binding interaction is reciprocal. Purified Strep-tagged Sec6 was immobilized on Strep-Tactin 
resin and incubated with purified Sec1. Input and bound samples were run on an 8% SDS–PAGE 
gel and stained with Coomassie blue dye. For all experiments, Hc and Lc refer to the heavy and 
light chains of the α-V5 antibody, respectively. To avoid leakage of proteins between different 
lanes, gels were often run with empty lanes between input and bound; empty lanes from the 
same gel were edited out using Photoshop. For all experiments, representative gels are shown 
for at least three repetitions.
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membrane (Boyd et al., 2004; He et al., 
2007). The major peak of Sec1 was found as 
a high molecular weight species (appar-
ent molecular weight >1 MDa), which par-
tially overlaps with the exocyst complex 
peak. The mobility of Sec1 is consistent with 
a small fraction of Sec1 interacting with the 
exocyst (Wiederkehr et al., 2004), with the 
majority either interacting with other bind-
ing partners or oligomerizing. Conversely, 
Sec9 was predominantly found as a lower 
molecular weight species, with mobility 
overlapping that of the non–exocyst-bound 
pool of Sec6. The apparent molecular 
weight (∼600 kDa) of Sec9 is also much 
larger than expected for a monomer 
(74 kDa), suggesting oligomerization and/or 
interactions with other partners. In addition, 
many of the proteins were present in the 
void volume (∼8 ml) of the column, indicat-
ing that they were forming large oligomers 
or aggregates. The gel filtration studies sup-
port the idea that the Sec6–Sec1 interaction 
occurs within the exocyst complex, but that 
Sec6–Sec9 is excluded from the exocyst 
complex.
Regulation of binary SNARE complex 
assembly
The rate-limiting step in SNARE complex as-
sembly is Sec9 binding to the syntaxin Sso1 
(or its homologue Sso2; Nicholson et al., 
1998). Formation of the Sec9–Sso1 complex 
is inhibited in vitro and in vivo by the N-terminal autoinhibitory do-
main of Sso1 (Nicholson et al., 1998; Munson et al., 2000; Munson 
and Hughson, 2002). This Sso1 autoinhibition must be specifically 
released upon vesicle arrival at sites of secretion to facilitate assem-
bly of the t-SNARE complex. Subsequently, the v-SNARE Snc2 (or its 
homologue Snc1) binds, leading to membrane fusion (Nicholson 
et al., 1998). The factor(s) that release the Sso1 inhibition are 
unknown.
We originally hypothesized that the exocyst subunit Sec6, be-
cause it binds Sec9, might be the factor that releases the Sso1 inhi-
bition, opening it for SNARE complex assembly. Instead, addition of 
purified Sec6 inhibits formation of the binary Sso1–Sec9 SNARE 
complex by ∼3.5-fold (Sivaram et al., 2005; Figure 6A). The likely 
explanation is that Sso1 has an infrequent rate of spontaneous 
opening; when Sso1 does become open, Sec9 is unavailable be-
cause it is bound to Sec6, lowering the effective concentration of 
free Sec9 and slowing the rate of SNARE assembly. This Sec6 inhibi-
tion of SNARE complex assembly is supported by yeast genetic ex-
periments. Overexpression of Sec6, which is not toxic to wild-type 
yeast cells, shows a strong synthetic effect when combined with the 
sec9-4 temperature-sensitive mutation, inhibiting cell growth 
(Figure 6B). In contrast, overexpression of either the exocyst subunit 
Sec5, or Sec1, which is proposed to have a positive role in SNARE 
complex assembly and membrane fusion, has no effect on the 
growth of sec9-4 cells.
One possibility for the requirement of Sec1 prior to SNARE com-
plex assembly (Hashizume et al., 2009) is that Sec1 would bind Sec6 
in order to release the inhibited Sec6–Sec9 intermediate, to drive 
binary SNARE complex assembly. However, consistent with the 
of exocyst subunits. Sec1 was immobilized on the resin and pre-
bound to Sec6. After washing to remove the unbound Sec6, an 
equimolar mixture of Exo70, Sec10, and Exo84CT was added. The 
exocyst subunits were able to weakly interact with the Sec6–Sec1 
complex (Figure 5A). Exo70 showed the most robust interaction, 
while Sec10 and Exo84CT also showed some nonspecific binding 
to the resin. In contrast, Sec6 bound to immobilized MBP-Sec9CT 
did not interact with the exocyst subunits (Figure 5B). Together, 
these data indicate that Sec1 can interact with Sec6 in the presence 
of the other exocyst subunits and may form a weak or transient 
complex with the exocyst in vivo. In contrast, Sec9 appears to com-
pete with exocyst subunits for Sec6 binding.
Gel filtration studies also supported this idea. Sec1, Sec9, and 
the exocyst subunits from yeast lysates were run on an analytical 
gel filtration column and their mobility monitored by Western blot 
analyses (Figure 5C). We previously showed that Sec6 is present in 
both exocyst-bound and non-exocyst-bound fractions, although 
the magnitudes of the pools varied substantially between different 
experiments (Sivaram et al., 2005). We originally proposed that 
the nonexocyst pool contained a dimer of Sec6 because it mi-
grated with approximately twice the molecular weight of Sec6, but 
we could not rule out other complexes containing Sec6. Here we 
found that assembled exocyst complexes migrated as a clear peak 
(∼10–12.5 ml), with an apparent molecular weight of >1 MDa. A 
nonexocyst pool of Sec6 (93 kDa) is observed (apparent molecular 
weight ∼250 kDa), which comigrated with a fraction of Sec8 
(122 kDa). A non-exocyst-bound pool of Exo70 was also observed 
(apparent molecular weight ∼70 kDa), consistent with a monomeric 
pool of Exo70 (molecular weight 71 kDa) that exists at the plasma 
FIGURE 2: Sec1–SNARE interactions. (A) Purified binary and ternary SNARE complexes were 
incubated with immobilized Sec1-V5-His6. Input and bound samples were run on a 15% 
SDS–PAGE gel and stained with Coomassie blue dye. (B, C). Titration of increasing 
concentrations of Sso1 or Sec9 to immobilized Sec1-V5-His6. Bound samples were run on 12% 
SDS–PAGE gels and stained with Coomassie blue dye. Some background binding of Sec9 to 
Sec1 is observed at high concentrations of Sec9 (30 μM).
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fact, addition of Sec1 alone slightly inhibited the reaction, although 
not to the same extent as Sec6, presumably due to the weakly com-
peting Sec1–Sec9 and Sec1–Sso1 interactions (Figure 2, B and C). In 
contrast, the Exo84CT subunit, which does not directly interact with 
Sec6 in the absence of other exocyst subunits, has no effect on the 
rate of binary SNARE complex assembly. Thus, the Sec1–Sec6 inter-
action alone is not sufficient to promote the SNARE complex as-
sembly reaction in vitro.
DISCUSSION
SM proteins and tethering complexes are two separate families of 
proteins known to be intimately involved in the final stages of mem-
brane trafficking, through both their recognition of vesicle and tar-
get membranes and their interactions with the membrane-fusing 
SNARE proteins. However, their mechanisms of action have been 
enigmatic (Carr and Rizo, 2010; Yu and Hughson, 2010), possibly 
because these proteins have been studied independently.
Here we uncover a molecular link between these families—the 
exocyst subunit Sec6 directly binds the exocytic SM protein Sec1. 
Importantly, Sec6 is the exocyst subunit that binds the t-SNARE 
Sec9, thus inhibiting Sec9 from forming SNARE complexes with its 
partner syntaxin Sso1 in vitro (Sivaram et al., 2005). Sec6–Sec1 is 
compatible with Sec6–exocyst interactions, whereas Sec6 and Sec9 
interact in the absence of the other exocyst subunits (Figure 5). 
inability of Sec1 to robustly compete with Sec9 for Sec6 binding 
(Figure 3), we found that addition of Sec1 to the Sec6-containing 
reaction did not increase the rate of SNARE assembly (Figure 6A). In 
FIGURE 3: Sec9 competes with Sec1 for binding Sec6. Analytical gel 
filtration runs (Superdex 200 column) of purified Sec1, Sec6, Sec9CT, 
and the various combinations were monitored by the absorbance at 
280 nm. Retention volumes of γ-globulin (158 kDa) and ovalbumin 
(44 kDa) standards are shown for comparison. The presence of each 
protein in the fractions was determined by Western blot analyses 
using α-V5 for Sec1, α-Sec6, and α-Sec9 antibodies. Note that the 
molar extinction coefficient of Sec9 at 280 nm is ∼30-fold less than 
that of Sec6 and Sec1.
FIGURE 4: Sec6 interacts with Sec9 and Sec1 in vivo. 
(A) Immunoprecipitation of Sec6-HA3 from yeast lysates with α-HA 
antibody pulls down endogenous full-length Sec9 and Sec9 protein 
overexpressed from a 2μ plasmid. The input and bound samples were 
run on 8% SDS–PAGE and immunoblotted for Sec6 and Sec9. (B) Sec1 
immunoprecipitated from yeast lysates binds endogenously 
expressed Sec6-HA3. The input and bound samples were run on 8% 
SDS–PAGE and immunoblotted for V5 and HA epitope tags.
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weak interactions with both Sso1 and Sec9 (Kd > 10 μM; Figure 2), 
supporting the idea that Sec1 and Sec6–exocyst may work together 
to facilitate proper SNARE complex assembly.
We propose that the Sec6–Sec1 interaction is critical for target-
ing Sec1 to sites of polarized secretion. The weak interactions be-
tween Sec1 and the individual SNARE proteins are not likely to re-
cruit Sec1; furthermore, neither Sso1 nor Sec9 localizes specifically 
to sites of secretion on the plasma membrane (Brennwald et al., 
1994). In contrast, Sec6 is critical for anchoring the exocyst complex 
at sites of secretion on the plasma membrane (Songer and Munson, 
2009). We propose that exocyst-bound Sec6 recruits Sec1 to sites of 
secretion, where it is handed off to newly formed ternary SNARE 
complexes for membrane fusion (Scott et al., 2004). Consistent with 
this idea, destabilization or mislocalization of the exocyst complex, 
for example, in the sec6-4 mutant, leads to loss of Sec1 localization 
(Grote et al., 2000).
In contrast to Sec1 recruitment, Sec6 is not a likely candidate to 
be the factor that recruits Sec9 to the plasma membrane. Unlike its 
homologue SNAP-25, Sec9 has no lipid modifications to anchor it 
and thus requires a binding partner on the plasma membrane. More-
over, Sec9 is dispersed throughout the plasma membrane, whereas 
Sec6 and Sec1 are specifically polarized to sites of secretion. Instead, 
Furthermore, the N-terminal domain of Sec6 is required for both 
Sec6–Sec1 and Sec6–Sec9 (Sivaram et al., 2005; Figure 1B), sug-
gesting that the binding sites on Sec6 may be overlapping for Sec1 
and Sec9. Consistent with these data, we were unable to detect a 
Sec6-Sec1-Sec9 ternary complex (Figure 3) or any Sec6–Sec1 com-
plexes in the presence of Sec9 (Figure 3). These data suggest a 
model in which Sec6–exocyst coordinates with Sec1 to regulate 
SNARE complex assembly.
Sec1 had appeared to be an outlier of the SM protein family; 
unlike other SM proteins, it did not seem to interact with individual 
SNARE proteins (Carr et al., 1999; Scott et al., 2004; Togneri et al., 
2006), but instead bound ternary Sso1-Sec9-Snc2 complexes 
(Togneri et al., 2006). In fact, Sec1 and Sso1 lack the conserved 
binding sites observed for SM proteins bound to the N-peptides of 
their cognate syntaxins (Bracher and Weissenhorn, 2002; Peng and 
Gallwitz, 2004; Arac et al., 2005; Carpp et al., 2006; Hu et al., 2007; 
Burkhardt et al., 2008; Furgason et al., 2009; Xu et al., 2010). These 
data suggested that Sec1 has a role downstream of SNARE complex 
assembly, perhaps driving SNARE-mediated membrane fusion 
(Scott et al., 2004). However, characterization of novel Sec1 mutants 
recently uncovered a role for Sec1 prior to SNARE complex assem-
bly (Hashizume et al., 2009). Our in vitro binding assays revealed 
FIGURE 5: Sec1 interacts with exocyst-bound Sec6, whereas Sec9 interacts with non-exocyst-bound Sec6. (A) In vitro, 
purified exocyst subunits were added simultaneously at 1.5 and 5 μM concentration to preformed immobilized 
Sec1-V5-His6-Sec6 complexes. After 1 h of incubation at 4°C, input and bound samples were run on 8 and 12% 
SDS–PAGE and stained with Coomassie blue dye. (B) Similar experiments were performed using MBP-Sec9 immobilized 
on amylose resin. Purified exocyst subunits (5 μM) were incubated with immobilized Sec9 or preformed Sec9–Sec6 
complexes. Bound proteins were run on SDS–PAGE gels and stained with Coomassie blue dye. Asterisk indicates a 
degradation product of the MBP-Sec9 protein. (C) Superose 6 10/30 analytical gel filtration of yeast lysates was 
analyzed by Western blot analyses using specific polyclonal antibodies. Band intensities were normalized to the most 
intense band as visualized by ECL, data points were averaged over three runs, and the error bars represent mean ± 
SEM.
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The exocyst and Sec1 are also likely to 
interact with the Sso1 opener, whose iden-
tity is unknown. Evidence suggests that 
Caenorhabditis elegans Unc13 and the 
mammalian Munc13 may provide this func-
tion for Munc18-bound syntaxin-1 (Betz 
et al., 1997; Richmond et al., 2001; Guan 
et al., 2008; Ma et al., 2011). There is no ob-
vious homologue for Munc13 in yeast; the 
most likely candidate(s) are members of the 
exocyst complex, which were recently shown 
to be structurally homologous to the MUN 
domain of Munc13 (Li et al., 2011). However, 
no opening activity has been directly ob-
served for any exocyst subunit or the 
complex.
The cooperation between Sec1 and the 
exocyst represents a general phenomenon 
for SM proteins and their partner tethering 
complexes. For example, the vacuolar SM 
protein Vps33 is an essential component of 
the class C/HOPS complex (Sato et al., 
2000; Seals et al., 2000). Sly1, the SM pro-
tein that regulates traffic between the endo-
plasmic reticulum and Golgi, was recently 
shown to interact with the assembled COG 
complex (Laufman et al., 2009). Interactions 
between tethering complexes and SM pro-
teins have been shown to be important for 
proofreading SNARE complexes and/or for 
SNARE complex formation (Koumandou 
et al., 2007; Starai et al., 2008; Laufman 
et al., 2009), suggesting that Sec1-Sec6-
exocyst may add further regulation and 
specificity to the fusion process.
Elucidation of these interactions is a criti-
cal step toward understanding the molecu-
lar mechanism(s) underpinning the regula-
tion of specific SNARE complex assembly. 
Future studies will require reconstitution and testing of assembled 
exocyst complexes and generation of novel separation-of-function 
mutants to further characterize these events. In addition, tethering 
complexes and SM proteins are not the only regulators at these 
sites; in yeast, the tomosyn homologue Sro7 interacts with Sec9 and 
the exocyst to form a parallel regulatory pathway (Lehman et al., 
1999; Zhang et al., 2005; Grosshans et al., 2006), and a fungal-spe-
cific Sec1 cofactor, Mso1, may bridge Sec1 and Sso1 to facilitate SM 
recruitment and SNARE regulation (Castillo-Flores et al., 2005; 
Weber et al., 2010; Weber-Boyvat et al., 2011). Their precise role in 
these processes and their potential cooperation with the exocyst 
and Sec1 require further study. Identification of the factor responsi-
ble for triggering the open conformation of Sso1, in combination 
with the known regulatory proteins and SNAREs, will lead to a more 
complete picture of how SNAREs are inhibited and then released at 
the proper time and place for specific vesicle docking and fusion.
MATERIALS AND METHODS
Protein expression and purification
Recombinant Sec6 (1–805; Sivaram et al., 2005), Exo70 (63–623; 
Dong et al., 2005), Exo84CT (523–753; Dong et al., 2005), Sec10 
(145–827; Croteau et al., 2009), Sec8 (Sivaram et al., 2006), and the 
cytoplasmic regions of the SNARE proteins Sso1, Snc2, and Sec9CT 
we propose that Sec6–Sec9 holds Sec9 in an inactive state (perhaps 
an assembly intermediate) at sites of secretion, where Sso1 becomes 
activated, to prevent premature or inappropriate SNARE assembly 
and vesicle fusion. The small amount of Sec6 that is Sec9 bound 
(Figure 4) is consistent with the low abundance of Sec9 localized to 
sites of exocytosis.
What releases Sec6 from Sec9 to drive SNARE complex assem-
bly? At sites of secretion, a small amount of unbound Sso1 and 
Sec9 would be present. The factor that opens Sso1 would also be 
localized to these sites; any SNARE complex assembly caused by 
premature opening of Sso1 at these sites would be blocked by the 
Sec6–Sec9 interaction. Vesicle arrival would then trigger exocyst as-
sembly (Boyd et al., 2004), leading to the release of Sec6 from Sec9, 
concomitant with Sso1 opening. These changes may also occur 
concurrently with Sec1 recruitment to provide coordinated regula-
tion of vesicle arrival, tethering, and production of fusion-ready 
SNARE complexes. Individually, the Sec6–exocyst interactions are 
weak and do not compete with Sec9 for binding Sec6; however, the 
multivalent combination of exocyst subunits would likely be strong 
enough to release Sec9. Furthermore, it is possible that in the cell, 
Sec1 may exist at a high enough local concentration at sites of se-
cretion to drive Sec9 release, likely in conjunction with exocyst 
assembly.
FIGURE 6: Sec6 inhibition of SNARE complex assembly. (A) Sec6 inhibits Sec9–Sso1 formation; 
this is not relieved by addition of Sec1. Purified Sec6 ± Sec1 proteins were incubated at 
equimolar concentrations with Sso1 and Sec9 for 0 or 8 h at 18°C to allow SNARE complex 
assembly. Reactions were run on 6% native PAGE gels and stained with Coomassie blue. 
Representative gels (more than three experiments at four different time points were run) for the 
0 h (middle) and 8 h (right) time points are shown; the uncomplexed proteins were run on a 
separate gel for comparison (left). Asterisk indicates the mobility of the Sso1–Sec9 complex. 
(B) Overexpression of SEC6, but not SEC5 or SEC1, has a synthetic defect when combined with 
sec9-4. Tenfold dilution series of wild-type or sec9-4 strains, transformed with vector alone, 
Gal-SEC6, Gal-SEC5, or Gal-SEC1-V5-His6, were plated on SC-leu or SC-ura plates, respectively, 
containing either glucose or galactose, and incubated at the indicated temperatures.
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centrations of purified Sec6 (from 0.5 to 3 μM) were added to im-
mobilized V5-Sec1 on protein G resin. The apparent Kd was esti-
mated from a one-site binding curve fit to the data (GraphPad Prism 
5 Software, La Jolla, CA), obtained by plotting the fractional satura-
tion of Sec1 as a function of the total concentration of Sec6 in the 
binding reaction (apparent Kd is average ± SE from three experi-
ments). Each data point represents a normalized Coomassie-stained 
band intensity determined by densitometry.
Immunoprecipitations
For the Sec6–Sec9 immunoprecipitations, the yeast strains were 
grown at 30°C until OD600 of 1.5–2.0. One hundred fifty OD600 units 
were pelleted and stored at −80°C until use. Pellets were thawed 
into and washed in 50 ml of 50 mM NaPO4, pH 7.4, resuspended in 
5 ml of spheroplasting buffer (50 mM NaPO4 pH 7.4, 1.5 M sorbitol, 
10 mM NaN3, 35 mM β-mercaptoethanol), and incubated at 35°C 
for 40 min at 80 rpm. The resulting spheroplasts were layered onto 
5 ml of sorbitol solution (50 mM NaPO4, pH 7.4, 1.5 M sorbitol) and 
spun at 1000 × g for 10 min. Spheroplasts were lysed using 0.4 ml of 
lysis buffer (20 mM HEPES, pH 7.4, 150 mM KCl, 1 mM EDTA, 1 mM 
DTT, 0.5% NP-40, and protease inhibitors), and lysate was cleared at 
15,600 × g for 15 min at 4°C. Lysate protein levels were equalized 
using a Bio-Rad (Hercules, CA) protein concentration assay. Equal 
protein levels were diluted to 250 μl with lysis buffer and incubated 
with 40 μl of protein G–coupled beads and 1:200 dilution α-HA an-
tibody for 1 h at 4°C. Beads were washed in 300 μl of lysis buffer, and 
the bound proteins versus input were separated by SDS–PAGE. 
Sec6 and Sec9 were detected by immunoblotting with the appropri-
ate primary antibody, α-rabbit IgG (Roche), and then developed 
with ECL (Amersham, Piscataway, NJ) and imaged using the LAS-
3000 (Fujifilm, Tokyo, Japan) and image reader LA-3000 (Fujifilm).
For the V5-Sec1 immunoprecipitations, yeast expressing His6-
V5-Sec1 were induced in SC-URA plus 2% galactose shaking for 7 h 
at 30°C. Pellets, 100 OD, were frozen and stored at −80°C. Each 
100-OD pellet was resuspended in 400 μl of lysis buffer (50 mM 
HEPES, 100 mM NaCl, 1 mM EDTA, 1 mM PMSF, 0.5 mM DTT, 0.5% 
NP-40, Complete Mini Protease Inhibitor [Roche]) and lysed by vor-
texing with 50% slurry of 0.5-mm zirconia/silica beads (BioSpec, 
Bartlesville, OK). Lysates were centrifuged at 13,000 rpm and then 
at 100,000 × g (Beckman TLA100) to clear cellular debris. The super-
natant was then precleared with 15-μl bed volume of protein G–
Sepharose beads (Roche) for 30 min, and the protein concentration 
was determined by Bio-Rad protein assay. Lysates were equalized 
for total protein content and then incubated with α-V5 (Invitrogen) 
and 20-μl bed volume of protein G–Sepharose beads for 1.5 h. 
Beads were washed three times with 500 μl of chilled lysis buffer. 
Beads were resuspended in 40 μl of 1× SDS–PAGE loading buffer, 
separated by SDS–PAGE, and analyzed by Western blotting.
Gel filtration analyses
For in vitro analyses using purified Sec6, Sec1, and Sec9 proteins, 
200 μl of 5 μM each (individually and in combinations) was loaded 
on a Superdex 200 30/10 column (GE Healthcare) equilibrated in K 
phosphate buffer (10 mM potassium phosphate, pH 7.4, 140 mM 
KCl, 1 mM DTT; bed volume, 24 ml). Eluted proteins were located 
by monitoring the absorbance at 280 nm. The gel filtration column 
was previously calibrated using standards (Bio-Rad).
For analyses of exocyst subunits, Sec1 and Sec9 proteins from 
yeast lysates, MMY205 (MATα sec6Δ::KanMX-4 his3Δ1 leu2Δ0 
ura3Δ0 [LEU2 CEN SEC6]) cells were grown to OD600 1.5–2.0 and 
stored as 150-OD600 pellets at −80°C. Pellets were thawed into and 
washed in 50 ml of 50 mM NaPO4, pH 7.4, resuspended in 5 ml of 
(416–651) (Nicholson et al., 1998) were overexpressed in Escherichia 
coli and purified as described. Note that this C-terminal Sec9 con-
struct used in all the in vitro studies is the domain of Sec9 homolo-
gous to the mammalian SNAP-25 protein and is sufficient for Sec9 
function in yeast (Brennwald et al., 1994).
C-terminally V5-His6 tagged Sec1 was expressed in Saccharomy-
ces cerevisiae from the pYES/CT Sec1-V5-His6 plasmid (Togneri 
et al., 2006). After induction with 2% galactose for 8–10 h, cells were 
harvested and resuspended in wash buffer (20 mM Tris, 20 mM 
NaF, 20 mM NaN3, pH 7.5). Lysis was performed using a Microfluid-
izer 110S (Microfluidics, Newton, MA) cell disruptor in 50 mM 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 150 mM 
KCl, 15 mM imidazole, and 10% glycerol, pH 7.4, in the presence of 
phenylmethylsulfonyl fluoride (PMSF; 1 mM), β-mercaptoethanol 
(5 mM), and protease inhibitor tablets (Roche, Indianapolis, IN). 
Lysate was clarified by centrifugation (13,000 rpm, 30 min), and the 
supernatant was ultracentrifuged to remove aggregated particles 
(37,000 rpm, 40 min, in a Beckman 50.2 Ti rotor [Beckman Coulter, 
Brea, CA]). Sec1 was purified on nickel-nitriloacetic acid (Ni NTA) 
resin (Qiagen, Valencia, CA) and eluted with 200 mM imidazole. 
Fractions were analyzed by SDS–PAGE and Coomassie blue staining; 
those fractions containing pure Sec1 were pooled and exchanged 
into 50 mM HEPES, 250 mM KCl, 10% glycerol, and 1 mM dithiothre-
itol (DTT), pH 7.4 buffer, using a PD10 column (GE Healthcare Piscat-
away, NJ). All proteins (except Sec8, which is sparingly soluble) were 
>90% pure, as assayed by SDS–PAGE. Protein concentrations were 
determined by quantitative ninhydrin protein assay (Rosen, 1957).
In vitro binding assays
All binding experiments were repeated at least three times, and rep-
resentative data are shown for each. For in vitro binding of Sec1 to 
recombinant proteins, 0.8 μg (∼0.2 μM) of purified Sec1-V5-His6 was 
immobilized on protein G beads using α-V5 antibody (Invitrogen, 
Carlsbad, CA) and washed with binding buffer (50 mM HEPES, 
150 mM KCl, 10% glycerol, 0.5% NP-40, 1 mM DTT, pH 7.4) lacking 
protease inhibitors. Purified proteins or purified protein complexes 
(1–2 μM) (purified exocyst subunits and SNAREs) were then added 
to the immobilized Sec1, and the mixture was incubated for 2 h at 
4°C with mixing. Beads were washed with binding buffer, and the 
bound beads and supernatant were run on SDS–PAGE gels. Gels 
were either stained with Coomassie blue or analyzed by immunob-
lotting with α-His5 antibody (Qiagen).
For in vitro binding of Sec9 to exocyst subunits (individually or in 
combinations), MBP-tagged Sec9 protein was purified using amy-
lose agarose affinity chromatography (New England BioLabs, Ips-
wich, MA). The purified protein immobilized on the amylose beads 
was then washed in potassium phosphate buffer and incubated for 
1 h at 4°C with equimolar concentration of purified proteins. Beads 
were washed with the binding buffer, and then beads and superna-
tant were separated by SDS–PAGE and stained with Coomassie 
blue.
Similarly, C-terminally Strep-tagged Sec6 (WSHPQFEK) was im-
mobilized on Strep-Tactin beads (engineered streptavidin from IBA 
GmbH, Göttingen, Germany) and washed with binding buffer 
(50 mM HEPES, 150 mM KCl, 10% glycerol, 0.5% NP-40, 1 mM DTT, 
pH 7.4). Equimolar purified His-V5-Sec1 (1 μM) was added to the 
Strep-Tactin beads alone and to the beads with the immobilized 
Sec6 and incubated for 1 h at 4°C. Beads were washed with the 
binding buffer, and then beads and supernatant were separated by 
SDS–PAGE and stained with Coomassie blue.
The apparent binding affinity for the Sec1–Sec6 complex was 
estimated by using the in vitro V5 pull-down assay. Increasing con-
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spheroplasting buffer (50 mM NaPO4, pH 7.4, 1.5 M sorbitol, 10 mM 
NaN3, 35 mM β-mercaptoethanol), and incubated at 35°C for 
40 min, gently shaking at 80 rpm. The resulting spheroplasts were 
layered onto a 5 ml of sorbitol solution (50 mM NaPO4, pH 7.4, 
1.5 M sorbitol) and spun at 1000 × g for 10 min. Spheroplasts were 
lysed using 0.3 ml of lysis buffer (20 mM HEPES, pH 7.4, 150 mM 
KCl, 1 mM EDTA, 1 mM DTT, 0.5% NP-40, and protease inhibitors), 
and lysate was cleared at 15,000 × g for 40 min at 4°C. Lysate, 
200 μl, was loaded into a Superose 6 gel filtration column (GE 
Healthcare) in lysis buffer without protease inhibitors. Fractions were 
analyzed for the presence of each protein by immunoblotting using 
specific rabbit antibodies. Band intensities were determined in Pho-
toshop CS5 (Adobe, San Jose, CA) by taking the average pixel in-
tensity of the band, subtracting out the average pixel intensity of a 
background sample of equal size from the same lane, and normal-
izing to a loading control band. Each protein was normalized to the 
highest band intensity for averaging and SE calculations. Apparent 
molecular weights were calculated using standard curves generated 
using known molecular weight standards (Bio-Rad).
SNARE complex assembly assays
Native gel mobility shift assays were performed essentially as de-
scribed (Nicholson et al., 1998; Sivaram et al., 2005). Purified pro-
teins were incubated together at equimolar concentrations (2 μM) in 
binding buffer (50 mM HEPES, 150 mM KCl, pH 7.5) at 18°C for 
0–24 h (0 and 8 h are shown). Proteins were loaded onto 6% native 
polyacrylamide gels and buffered at pH 7.4 with 215 mM imidazole 
and 175 mM HEPES for native gel mobility shift assays. The gels 
were run at 30 mA for 85 min at 4°C and stained with Coomassie 
blue.
Yeast methods
SEC6 and SEC5 were overexpressed from the Gal-expression vector 
pPP450 (Peter Pryciak, University of Massachusetts Medical School, 
Worcester, MA) in wild-type (BY4741; Open Biosystems, Thermo 
Biosystems, Huntsville, AL) and sec9-4 (MMY623; Songer and 
Munson, 2009) strains. Sec1-V5-His6 was overexpressed from pYES/
CT (Invitrogen) in wild-type (NY179; Novick et al., 1980) and sec9-4 
(BY68; Brennwald et al., 1994) strains. Media, growth conditions, 
and genetic methods for yeast were used as described (Munson 
et al., 2000).
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